Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Incyte Corporation (Nasdaq: INCY)

Incyte is a Wilmington, Delaware-based drug discovery and development company with a growing pipeline of oral compounds to treat HIV, inflammation, cancer and diabetes. *

 

  Group Incyte Corporation (Group)
Product Industry genomics/genetics
     
  Street Experimental Station, Route 141 & Henry Clay Road, Bldg. E336
  City 19880 Wilmington, DE
  Tel +1-302-498-6700
    Address record changed: 2018-07-24
     
Basic data Employees n. a.
  Currency USD
  Annual sales 34,440,000 (revenue, consolidated (2007) 2007-12-31)
  Profit -86,881,000 (2007-12-31)
  Cash 257,327,000 (2007-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2020-01-13

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Incyte Corporation (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] Made Without Love 650x80px




» top